0,814  0,002  Antiparkinsonian, rigidity relieving
0,774  0,015  Caspase 9 stimulant
0,752  0,005  5 Hydroxytryptamine release stimulant
0,669  0,004  Skeletal muscle relaxant
0,669  0,004  Muscle relaxant
0,627  0,003  Neurotrophic factor enhancer
0,613  0,015  Antidepressant
0,590  0,005  5 Hydroxytryptamine antagonist
0,589  0,005  5 Hydroxytryptamine 2 antagonist
0,593  0,019  Mood disorders treatment
0,570  0,005  Sigma receptor agonist
0,554  0,010  DNA damaging
0,532  0,004  5 Hydroxytryptamine 2A antagonist
0,530  0,004  Alpha 2 adrenoreceptor antagonist
0,528  0,006  Topoisomerase II inhibitor
0,537  0,019  CYP1A2 substrate
0,535  0,031  Antineoplastic (colorectal cancer)
0,536  0,041  Antineoplastic (solid tumors)
0,524  0,030  Antineoplastic (colon cancer)
0,519  0,026  Respiratory analeptic
0,509  0,022  CYP2C19 inhibitor
0,468  0,004  Topoisomerase I inhibitor
0,507  0,044  Antineoplastic (lung cancer)
0,484  0,023  Caspase 3 stimulant
0,478  0,018  CYP2D6 inhibitor
0,457  0,007  Alpha adrenoreceptor antagonist
0,466  0,028  Hepatic disorders treatment
0,441  0,005  Antiparkinsonian, tremor relieving
0,436  0,004  Dopamine D1 antagonist
0,437  0,014  Antineoplastic (small cell lung cancer)
0,464  0,048  CYP3A4 substrate
0,461  0,045  Histamine release inhibitor
0,418  0,007  DNA intercalator
0,416  0,006  5 Hydroxytryptamine 1 antagonist
0,488  0,078  Apoptosis agonist
0,450  0,041  Prostate cancer treatment
0,425  0,022  Antineoplastic (lymphoma)
0,408  0,008  Dopamine antagonist
0,434  0,034  Spasmolytic
0,420  0,029  Antineoplastic (non-small cell lung cancer)
0,386  0,005  Alpha 2a adrenoreceptor antagonist
0,403  0,025  Cardiodepressant
0,417  0,057  CYP2C9 substrate
0,368  0,010  5 Hydroxytryptamine 2B antagonist
0,361  0,008  Dopamine D2 antagonist
0,378  0,027  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,361  0,013  Genotoxic
0,388  0,047  Anxiolytic
0,349  0,010  5 Hydroxytryptamine 1E antagonist
0,318  0,005  Alpha 2c adrenoreceptor antagonist
0,321  0,008  Carcinogenic, group 1
0,325  0,014  Liver fibrosis treatment
0,361  0,050  Antineoplastic (melanoma)
0,360  0,049  Antineoplastic (brain cancer)
0,359  0,048  Analeptic
0,378  0,071  Antileukemic
0,390  0,083  Antineoplastic (breast cancer)
0,355  0,049  CYP3A4 inhibitor
0,342  0,037  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,332  0,029  Abortion inducer
0,312  0,009  CDC-like kinase 1 inhibitor
0,311  0,009  5 Hydroxytryptamine 1A antagonist
0,321  0,019  Antineoplastic (squamous cell carcinoma)
0,325  0,025  P-glycoprotein inhibitor
0,354  0,058  Antihypertensive
0,329  0,033  Anticonvulsant
0,351  0,057  CYP2D6 substrate
0,299  0,008  5 Hydroxytryptamine agonist
0,376  0,085  15-Lipoxygenase inhibitor
0,334  0,050  Hypoxia-inducible factor 1 alpha inhibitor
0,287  0,006  5 Hydroxytryptamine 3E antagonist
0,322  0,041  Antineoplastic (glioblastoma multiforme)
0,287  0,010  Alpha 2b adrenoreceptor antagonist
0,306  0,032  Sedative
0,316  0,047  Dyrk kinase inhibitor
0,309  0,041  Antimitotic
0,292  0,026  Male reproductive disfunction treatment
0,327  0,064  Antineoplastic (ovarian cancer)
0,266  0,004  Antineoplastic alkaloid
0,303  0,042  Antineoplastic (bladder cancer)
0,302  0,042  Psychostimulant
0,275  0,019  Acetylcholine M1 receptor antagonist
0,298  0,043  Cyclic AMP phosphodiesterase inhibitor
0,305  0,050  Antineoplastic (renal cancer)
0,309  0,055  Antineoplastic (glioma)
0,266  0,014  Psychosexual dysfunction treatment
0,317  0,065  Antipsychotic
0,273  0,023  Tubulin antagonist
0,278  0,029  Pneumotoxic
0,252  0,004  CDC-like kinase 3 inhibitor
0,264  0,018  Acetylcholinesterase inhibitor
0,248  0,006  5 Hydroxytryptamine 1B antagonist
0,262  0,022  Erectile dysfunction treatment
0,265  0,025  Cholinergic
0,291  0,060  Antineoplastic (cervical cancer)
0,241  0,011  Topoisomerase II alpha inhibitor
0,234  0,005  Acetylcholine M4 receptor antagonist
0,282  0,055  Vasodilator
0,245  0,018  Antiadrenergic
0,236  0,008  Dopamine D3 antagonist
0,234  0,007  MAP3K9 inhibitor
0,241  0,018  Adrenaline antagonist
0,275  0,053  DNA synthesis inhibitor
0,241  0,019  Antiviral (Hepatitis B)
0,254  0,042  Hepatoprotectant
0,259  0,052  Clk dual-specificity kinase inhibitor
0,222  0,018  Butyrylcholinesterase inhibitor
0,261  0,058  Tyrosine 3 hydroxylase inhibitor
0,220  0,018  Alpha 1 adrenoreceptor antagonist
0,204  0,005  5 Hydroxytryptamine 5A antagonist
0,300  0,102  Prostaglandin dehydrogenase inhibitor
0,302  0,105  Cognition disorders treatment
0,223  0,026  Cholinergic antagonist
0,229  0,033  LDLR expression enhancer
0,252  0,058  MAP-kinase-activated kinase 5 inhibitor
0,319  0,128  Antiparkinsonian
0,194  0,005  Restless leg syndrome treatment
0,224  0,037  Antineoplastic (carcinoma)
0,209  0,022  Acetylcholine muscarinic antagonist
0,257  0,072  Tumour necrosis factor alpha release inhibitor
0,287  0,103  Vasodilator, peripheral
0,201  0,017  5 Hydroxytryptamine 2C antagonist
0,186  0,005  5 Hydroxytryptamine 5 antagonist
0,208  0,029  Acetylcholine antagonist
0,250  0,072  Antineoplastic (liver cancer)
0,283  0,105  Transcription factor NF kappa B inhibitor
0,213  0,035  CNS active muscle relaxant
0,256  0,080  Radiosensitizer
0,181  0,007  Phosphodiesterase V inhibitor
0,232  0,058  Mutagenic
0,240  0,073  Antineoplastic (lymphocytic leukemia)
0,276  0,109  Vasodilator, coronary
0,175  0,009  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,177  0,012  Dopamine agonist
0,201  0,037  Uterine stimulant
0,234  0,074  Cytostatic
0,177  0,019  Alpha 1a adrenoreceptor antagonist
0,166  0,009  Phosphodiesterase 5A inhibitor
0,196  0,040  ATPase inhibitor
0,163  0,008  Phosphodiesterase XI inhibitor
0,163  0,008  Phosphodiesterase 11A inhibitor
0,172  0,018  Breast cancer-resistant protein inhibitor
0,164  0,010  5 Hydroxytryptamine 1D antagonist
0,248  0,094  Radioprotector
0,172  0,020  Activin receptor-like kinase 4 inhibitor
0,239  0,098  CYP1A2 inhibitor
0,156  0,015  5 Hydroxytryptamine 1F antagonist
0,181  0,040  NADPH oxidase inhibitor
0,225  0,086  Antiprotozoal (Leishmania)
0,233  0,094  Antiprotozoal (Trypanosoma)
0,143  0,005  5 Hydroxytryptamine 2 agonist
0,205  0,067  Antimigraine
0,165  0,031  Pregnane X receptor agonist
0,182  0,047  Heat shock protein 90 antagonist
0,136  0,008  Alpha 2 adrenoreceptor agonist
0,145  0,018  5 Hydroxytryptamine 7 antagonist
0,243  0,118  Bone diseases treatment
0,195  0,070  CDC-like kinase 4 inhibitor
0,178  0,054  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,161  0,038  MAO A inhibitor
0,203  0,083  Antineoplastic enhancer
0,134  0,015  Phosphodiesterase 6D inhibitor
0,141  0,025  Carcinogenic, group 2A
0,129  0,014  Acetylcholine M2 receptor antagonist
0,162  0,048  Antiseptic
0,129  0,016  5 Hydroxytryptamine 1 agonist
0,127  0,014  Nicotinic alpha4beta2 receptor antagonist
0,177  0,065  Toxic, respiratory center
0,176  0,064  Phobic disorders treatment
0,141  0,030  Protein kinase C mu inhibitor
0,147  0,036  Antiviral (Papilloma)
0,149  0,038  Menstruation disorders treatment
0,173  0,063  Prostate disorders treatment
0,115  0,007  Heat shock protein 90 beta antagonist
0,112  0,005  Glutamate (mGluR7) antagonist
0,150  0,046  Alkylator
0,257  0,156  CYP2C9 inhibitor
0,104  0,005  5 Hydroxytryptamine 3B antagonist
0,204  0,105  Antipyretic
0,184  0,089  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,127  0,034  Prolactin inhibitor
0,122  0,029  Alpha 1b adrenoreceptor antagonist
0,201  0,108  Acute neurologic disorders treatment
0,125  0,032  Calcium antagonist
0,178  0,088  Anesthetic general
0,105  0,016  Protein kinase C eta inhibitor
0,099  0,011  Dopamine D2 agonist
0,104  0,016  5 Hydroxytryptamine 3 antagonist
0,114  0,028  Telomerase inhibitor
0,109  0,024  Dopamine D4 antagonist
0,192  0,107  NOS2 expression inhibitor
0,092  0,009  5 Hydroxytryptamine 7 agonist
0,099  0,018  Acetylcholine M3 receptor antagonist
0,090  0,009  5 Hydroxytryptamine 1B agonist
0,157  0,077  Cystic fibrosis treatment
0,091  0,010  Dopamine D5 antagonist
0,106  0,026  Antiviral (Hepatitis A)
0,147  0,068  Attention deficit/hyperactivity disorder treatment
0,158  0,079  Heat shock protein 90 alpha antagonist
0,150  0,072  Antiischemic, cerebral
0,202  0,125  Antiosteoporotic
0,131  0,054  Interleukin 1b antagonist
0,152  0,076  Antiviral (Herpes)
0,173  0,098  Pyruvate kinase inhibitor
0,130  0,055  DNA repair enzyme inhibitor
0,166  0,092  Antiviral (Hepatitis)
0,088  0,015  AMPA receptor antagonist
0,101  0,028  Alpha adrenoreceptor agonist
0,134  0,061  Antismoking
0,084  0,012  Nicotinic alpha3beta2 receptor antagonist
0,130  0,059  Papain-like protease (SARS coronavirus) inhibitor
0,095  0,024  Phosphodiesterase VI inhibitor
0,137  0,066  MAO inhibitor
0,079  0,010  Potassium channel small-conductance Ca-activated blocker
0,089  0,020  5 Hydroxytryptamine 2A agonist
0,203  0,135  Antiepileptic
0,080  0,011  Prolactin release inhibitor
0,150  0,082  Melanin inhibitor
0,086  0,018  5 Hydroxytryptamine 1A agonist
0,103  0,036  ATPase (Vacuolar H+) inhibitor
0,131  0,064  Bipolar disorder treatment
0,111  0,045  Nitric-oxide synthase inhibitor
0,140  0,074  Heat shock protein 70 antagonist
0,072  0,007  Endothelin receptor antagonist
0,120  0,055  Sphingosine 1-phosphate receptor 2 agonist
0,094  0,029  5 Hydroxytryptamine uptake inhibitor
0,140  0,075  Activin receptor-like kinase 2 inhibitor
0,169  0,105  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,160  0,096  Antineoplastic (bone cancer)
0,110  0,047  Estrogen receptor beta antagonist
0,085  0,023  Protein kinase C beta inhibitor
0,121  0,060  Interleukin 8 antagonist
0,076  0,014  5 Hydroxytryptamine 4 antagonist
0,203  0,144  Antineoplastic (multiple myeloma)
0,154  0,096  Catenin beta inhibitor
0,077  0,020  Potassium channel (Ca-activated) blocker
0,080  0,023  5 Hydroxytryptamine 6 antagonist
0,097  0,041  Acetylcholine nicotinic antagonist
0,129  0,073  Liver cirrhosis treatment
0,191  0,135  Antineoplastic (pancreatic cancer)
0,070  0,015  5 Hydroxytryptamine 2C agonist
0,076  0,021  Alpha tubulin antagonist
0,086  0,035  Antidote, organophosphates
0,115  0,065  Estrogen antagonist
0,083  0,034  Neuronal nicotinic receptor antagonist
0,080  0,031  Female sexual dysfunction treatment
0,068  0,020  Ryanodine receptor antagonist
0,139  0,092  UGT1A3 substrate
0,213  0,166  GST M1-1 substrate
0,091  0,045  mTOR complex 2 inhibitor
0,074  0,028  Acetylcholine M5 receptor antagonist
0,048  0,004  Imidazoline I1 receptor antagonist
0,055  0,013  Phosphodiesterase 6C inhibitor
0,222  0,181  GABA C receptor rho-3 antagonist
0,046  0,006  Endothelin B receptor antagonist
0,066  0,026  Protein kinase C epsilon inhibitor
0,069  0,031  Dopamine uptake inhibitor
0,058  0,020  Factor III inhibitor
0,135  0,097  MAP kinase kinase 4 inhibitor
0,215  0,177  Antiprotozoal (Plasmodium)
0,125  0,088  Protein kinase C nu inhibitor
0,042  0,007  Endothelin A receptor antagonist
0,075  0,041  Dysmenorrhea treatment
0,156  0,122  CYP2B6 inhibitor
0,043  0,010  Phosphodiesterase 6B inhibitor
0,092  0,060  SULT1E1 substrate
0,067  0,039  5 Hydroxytryptamine 3 agonist
0,046  0,019  GABA uptake inhibitor
0,058  0,031  Melanin-concentrating hormone receptor 1 antagonist
0,102  0,074  Protein kinase C gamma inhibitor
0,037  0,010  Dopamine autoreceptor agonist
0,101  0,074  DOPA decarboxylase inhibitor
0,133  0,106  CDC-like kinase 2 inhibitor
0,161  0,135  Antihypercholesterolemic
0,057  0,032  Nicotinic receptor alpha7 subunit antagonist
0,096  0,070  Carcinogenic, group 2B
0,182  0,158  UGT1A9 substrate
0,043  0,019  Vesicle monoamine transporter inhibitor
0,059  0,037  Alpha 1 adrenoreceptor agonist
0,106  0,084  Antiprotozoal (Babesia)
0,075  0,054  Antitreponemal
0,181  0,161  Antineoplastic (sarcoma)
0,028  0,009  Phosphodiesterase 6H inhibitor
0,028  0,009  Phosphodiesterase 6G inhibitor
0,043  0,025  Acid-sensing ion channel blocker
0,047  0,030  Farnesyltransferase inhibitor
0,160  0,143  VEGF expression inhibitor
0,076  0,059  MAP kinase 7 inhibitor
0,097  0,080  Polo-like kinase-4 inhibitor
0,097  0,080  GABA receptor agonist
0,035  0,018  Protein kinase C beta II inhibitor
0,020  0,004  Imidazoline I2 receptor antagonist
0,186  0,170  Gastrin inhibitor
0,074  0,059  Estrogen receptor alpha antagonist
0,040  0,026  AMPA 4 receptor antagonist
0,064  0,053  Protein kinase C alpha inhibitor
0,105  0,095  Cyclooxygenase 3 inhibitor
0,130  0,120  Cytotoxic
0,067  0,057  Calcium channel L-type blocker
0,024  0,015  Dopamine D1 agonist
0,051  0,042  Postmenopausal disorders treatment
0,062  0,053  Acetylcholine M5 receptor agonist
0,065  0,056  Transforming growth factor antagonist
0,174  0,166  CYP2C19 substrate
0,053  0,044  Beta tubulin antagonist
0,084  0,077  Protein kinase C zeta inhibitor
0,124  0,117  GABA C receptor rho-2 antagonist
0,063  0,056  Premenstrual syndrome treatment
0,201  0,195  Stroke treatment
0,124  0,119  Carcinogenic
0,040  0,036  Nicotinic receptor alpha3 subunit antagonist
0,121  0,117  Prostatic (benign) hyperplasia treatment
0,058  0,054  Antiviral (Parainfluenza)
0,027  0,023  5 Hydroxytryptamine 6 agonist
0,163  0,160  Cardiotonic
0,020  0,018  Geranylgeranyltransferase inhibitor
0,022  0,021  Phosphodiesterase 6A inhibitor
0,042  0,041  Dopamine transporter inhibitor
0,086  0,086  Falcipain 3 inhibitor

